About
Genetic testing solutions
Areas of Focus
Categories
Genetics & GenomicsChina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
0
As Collaborator
6
Total Enrollment
2,713
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 5UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05980689Collaborator
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
PHASE2Recruiting
33 participants
Started: Oct 24, 2023 · Completed: Jan 31, 2025
NCT05969938Collaborator
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
N/AUnknown
50 participants
Started: Jun 21, 2023 · Completed: Aug 31, 2024
NCT05533892Collaborator
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
PHASE1Recruiting
30 participants
Started: Sep 1, 2022 · Completed: Feb 28, 2025
NCT05717738Collaborator
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
N/ARecruiting
300 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2024
NCT05713994Collaborator
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/ARecruiting
300 participants
Started: May 19, 2020 · Completed: Dec 30, 2025
Locations (1)
Headquarters
Shenzhen, China
Map
Loading map...